{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:28:39Z","timestamp":1717806519736},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.acuroe.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T18:08:29Z","timestamp":1712945309000},"page":"257-259","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation of new treatments for BCG-unresponsive non-muscle-invasive bladder cancer. Considerations in Latin America"],"prefix":"10.1016","volume":"48","author":[{"given":"Mario I.","family":"Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2024.03.003_bib0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.acuro.2024.01.008","article-title":"Documento multidisciplinar de consenso sobre el tratamiento actual del tumor vesical no-m\u00fasculo invasor que no responde al tratamiento con bacilo Calmette-Gu\u00e9rin","volume":"48","author":"Guerrero Ramos","year":"2024","journal-title":"Actas Urol Esp."},{"key":"10.1016\/j.acuroe.2024.03.003_bib0010","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1200\/JCO.23.00307","article-title":"Definitions, end points, and clinical trial designs for bladder cancer: recommendations from the Society for Immunotherapy of Cancer and the International Bladder Cancer Group","volume":"41","author":"Kamat","year":"2023","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.acuroe.2024.03.003_bib0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.eururo.2020.09.006","article-title":"Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita","volume":"78","author":"Teoh","year":"2020","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuroe.2024.03.003_bib0020","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, et al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer [Accessed 25 Feb 2024]. Available from: https:\/\/gco.iarc.who.int\/today."},{"key":"10.1016\/j.acuroe.2024.03.003_bib0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.clgc.2024.01.001","article-title":"Management of metastatic urothelial carcinoma in Emerging Markets (EM): an expert opinion","volume":"22","author":"Soares","year":"2024","journal-title":"Clin Genitourin Cancer."},{"key":"10.1016\/j.acuroe.2024.03.003_bib0030","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuroe.2024.03.003_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4081\/aiua.2021.1.1","article-title":"Bacillus Calmette-Guerin vaccine and bladder cancer incidence: scoping literature review and preliminary analysis","volume":"93","author":"Trigo","year":"2021","journal-title":"Arch Ital Urol Androl."},{"key":"10.1016\/j.acuroe.2024.03.003_bib0040","doi-asserted-by":"crossref","first-page":"77.e15","DOI":"10.1016\/j.urolonc.2017.10.005","article-title":"Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction bacillus Calmette-Gu\u00e9rin therapy","volume":"36","author":"Niwa","year":"2018","journal-title":"Urol Oncol."},{"key":"10.1016\/j.acuroe.2024.03.003_bib0045","first-page":"11380","article-title":"History of infantile BCG immunization did not predict lamina propria invasion and\/or high-grade in patients with non-muscle invasive bladder cancer","volume":"95","author":"MacDonald","year":"2023","journal-title":"Arch Ital Urol Androl."},{"key":"10.1016\/j.acuroe.2024.03.003_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2024.01.017","article-title":"Unlocking the potential of adequate Bacillus Calmette-Gu\u00e9rin immunotherapy in very-high-risk non-muscle-invasive bladder carcinoma: A multicenter analysis of oncological outcomes and risk dynamics","author":"Subiela","year":"2024","journal-title":"Eur Urol Oncol."},{"key":"10.1016\/j.acuroe.2024.03.003_bib0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/BLC-230047","article-title":"Comparative analysis of very reduced vs full dose BCG treatment for high-risk non-muscle invasive bladder cancer: a contemporary experience from Chile","volume":"9","author":"Grajales","year":"2023","journal-title":"Bladder Cancer."},{"key":"10.1016\/j.acuroe.2024.03.003_bib0060","first-page":"1","article-title":"Alternative therapies to Bacillus Calmette-Gu\u00e9rin shortage for nonmuscle invasive bladder cancer in Brazil and other underdeveloped countries: management considerations","volume":"5","author":"Wroclawski","year":"2019","journal-title":"J Glob Oncol."},{"key":"10.1016\/j.acuroe.2024.03.003_bib0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12094-023-03225-2","article-title":"Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology","volume":"26","author":"Fernandez Montes","year":"2024","journal-title":"Clin Transl Oncol."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578624000581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578624000581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T05:30:53Z","timestamp":1717738253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578624000581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2173578624000581"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2024.03.003","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation of new treatments for BCG-unresponsive non-muscle-invasive bladder cancer. Considerations in Latin America","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2024.01.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2024.03.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}